Understanding how our immune system fights bacterial infections
Regulation of TLR signaling, Inflammation and Antigen Presentation by VPS33B
This research explores how our immune cells recognize and respond to bacteria, aiming to improve how we fight off infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-11125809 on NIH RePORTER |
What this research studies
Our bodies have special sensors called Toll-like receptors (TLRs) that detect harmful bacteria and trigger an immune response. This project looks at how these sensors work both on the cell surface and inside cells, and how their signals lead to inflammation and help the immune system present parts of bacteria to other cells. We are particularly interested in a protein called Vps33B, which appears to play a key role in how immune cells process and respond to bacterial threats. By understanding Vps33B's function, we hope to uncover new ways to control the body's defense against infections.
Who could benefit from this research
Good fit: Patients experiencing bacterial infections could potentially benefit from future treatments developed based on this fundamental understanding of immune responses.
Not a fit: Patients without bacterial infections or those with conditions unrelated to immune system regulation of bacterial defense may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new strategies for treating bacterial infections by enhancing or modulating the body's natural immune responses.
How similar studies have performed: While the general mechanisms of immune recognition are known, the specific role of the Vps33B protein in regulating these pathways is a novel area of focus.
Where this research is happening
Cincinnati, United States
- Cincinnati Childrens Hosp Med Ctr — Cincinnati, United States (Active)
Researchers
- Principal investigator: Pasare, Chandrashekhar — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Pasare, Chandrashekhar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.